CTKBCytek BioSciences Inc
CTKB
Cytek BioSciences Inc300
Mkt Cap
$593.9MVolume
431,417.0052W High
$6.1852W Low
$2.37PE Ratio
-8.89CTKB Fundamentals
Price
$4.62Prev Close
$4.56Open
$4.5950D MA
$4.45Beta
1.32Avg. Volume
555,570.02EPS (Annual)
-$0.5209P/B
1.74Rev/Employee
$287,847.14$416.61
Cytek Biosciences (CTKB) Expected to Announce Earnings on Thursday
Cytek Biosciences (NASDAQ:CTKB) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-cytek-biosciences-inc-stock...
MarketBeat·2d ago
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives Average Recommendation of "Hold" from Analysts
Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB - Get Free Report) have been assigned an average rating of "Hold" from the six ratings firms that are covering the stock, Marketbeat.com reports. Two...
MarketBeat·11d ago
249,812 Shares in Cytek Biosciences, Inc. $CTKB Purchased by Tudor Investment Corp ET AL
Tudor Investment Corp ET AL bought a new position in shares of Cytek Biosciences, Inc. (NASDAQ:CTKB - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 249,812 shares of the company's stock, valued at a...
MarketBeat·17d ago
Tudor Investment Corp ET AL Invests $867,000 in Cytek Biosciences, Inc. $CTKB
Tudor Investment Corp ET AL purchased a new stake in shares of Cytek Biosciences, Inc. (NASDAQ:CTKB - Free Report) during the third quarter, according to the company in its most recent 13F filing...
MarketBeat·1mo ago
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives Consensus Recommendation of "Hold" from Brokerages
Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB - Get Free Report) have received a consensus recommendation of "Hold" from the six analysts that are presently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, two have given a hold rati...
MarketBeat·1mo ago
Topline Capital Management LLC Has $24.10 Million Position in Cytek Biosciences, Inc. $CTKB
Topline Capital Management LLC raised its stake in Cytek Biosciences, Inc. (NASDAQ:CTKB - Free Report) by 32.7% in the third quarter, according to the company in its most recent filing with the...
MarketBeat·2mo ago
Cytek Biosciences Highlights Aurora Evo, Recurring Revenue Growth and 2026 Outlook at TD Cowen Conference
Cytek Biosciences (NASDAQ:CTKB) outlined its recent product launches, geographic diversification, and expectations for 2026 during a presentation and fireside chat at TD Cowen's 42nd annual...
MarketBeat·2mo ago
Royce & Associates LP Increases Holdings in Cytek Biosciences, Inc. $CTKB
Royce & Associates LP boosted its holdings in shares of Cytek Biosciences, Inc. (NASDAQ:CTKB - Free Report) by 26.9% during the 3rd quarter, according to the company in its most recent 13F filing...
MarketBeat·2mo ago
Cytek Biosciences, Inc. (NASDAQ:CTKB) Given Consensus Rating of "Hold" by Brokerages
Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB - Get Free Report) have earned an average recommendation of "Hold" from the seven analysts that are presently covering the company, Marketbeat.com...
MarketBeat·2mo ago
Cytek Biosciences (NASDAQ:CTKB) Announces Quarterly Earnings Results, Misses Estimates By $0.36 EPS
Cytek Biosciences (NASDAQ:CTKB - Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.34) earnings per share for the quarter, missing the consensus estimate of...
MarketBeat·2mo ago
<
1
2
...
>